Effect of shock wave stimulation on hypertonic plantar flexor muscles in patients with cerebral palsy: A placebo-controlled study

Journal of Rehabilitation Medicine

Volumn 42, Issue 4, 2010, Pages 339-343

  Amelio, Ernesto ^a   Manganotti, Paolo ^b  

^a UNIVERSITY HOSPITAL OF VERONA   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

Author keywords

Cerebral palsy; Equinus foot; Extracorporeal shock wave therapy; Spasticity

Indexed keywords

ADULT; ARTICLE; CEREBRAL PALSY; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; JOINT CHARACTERISTICS AND FUNCTIONS; MALE; MUSCLE HYPERTONIA; PATHOPHYSIOLOGY; PES EQUINUS; RADIATION; SPASTICITY; TREATMENT OUTCOME;

ADULT; CEREBRAL PALSY; CHILD; EQUINUS DEFORMITY; FEMALE; HIGH-ENERGY SHOCK WAVES; HUMANS; MALE; MUSCLE HYPERTONIA; MUSCLE SPASTICITY; RANGE OF MOTION, ARTICULAR; TREATMENT OUTCOME;

EID: 77951901511     PISSN: 16501977     EISSN: None     Source Type: Journal    
DOI: 10.2340/16501977-0522     Document Type: Article

References (30)

1. Banks HH. The management of spastic deformities of the foot and ankle. Clin Orthop 1977; 122: 70-76.
2. Barwood S, Baillieu C, Boyd R. Analgesic effects of botulinum toxin A: a randomized, placebo-controlled clinical trial. Dev Med Child Neurol 2000; 42: 116-121.
3. Corry IS, Cosgrove AP, Duffy CM. Botulinum toxin A in hamstring spasticity. Gait Posture 1999; 10: 206-210.
4. Cosgrove AP, Corry IS, Graham HK. Botulinum toxin in the management of the lower limb in cerebral palsy. Dev Med Child Neurol 1994; 36: 386-396.
5. Fehlings D, Rang M, Glazier J. An evaluation of botulinum-A toxin injections to improve upper extremity function in children with hemiplegic cerebral palsy. J Pediatr 2000; 137: 331-337.
6. Eames NW, Baker R, Hill N. The effect of botulinum toxin A on gastrocnemius length: magnitude and duration of response. Dev Med Child Neurol 1999; 41: 226-232.
7. Bohannon R, Smith M. Interrater reliability of modified Ashworth scale of muscle spasticity. Phys Ther 1987; 67: 206-207.
8. Burbaud P, Wiart L, Dubos JL, Gaujard E, Debelleix X, Joseph PA, et al. A randomized, double-blind, placebo-controlled trial of botulinum toxin in the treatment of spastic foot in hemiparetic patients. J Neurol Neurosurg Psychiatry 1996; 61: 265-269.
9. Hesse S, Luecke D, Malezic M, Bertelt C, Friedrich H, Gregoric M. Botulinum toxin treatment for lower limb extensor spasticity in chronic hemiparetic patients. J Neurol Neurosurg Psychiatry 1994; 57: 1321-1324.
10. Dengler R, Neyer U, Wohlfarth K, Bettig U, Janzik HH. Local botulinum toxin in the treatment of spastic drop foot. J Neurol 1992; 239: 375-378.
11. Metaxiotis D, Siebel A, Doederlein L. Repeated botulinum toxin A injections in the treatment of spastic equinus foot. Clin Orthop Relat Res 2002; 394: 177-185.
12. Polak F, Morton R, Ward WA, Doderlein L, Siebel A. Double-blind comparison study of two doses of botulinum toxin A injected into calf muscles in children with hemiplegic cerebral palsy. Dev Med Child Neurol 2002 44: 551-555.
13. Falso M, Fiaschi A, Manganotti P. Pedobarometric evaluation of equines foot disorder after injection of botulinum toxin A in children on cerebral palsy: a pilot study. Dev Med Child Neurol 2005; 47: 396-402 (Pubitemid 40740498)
14. Russo S, Marlinghaus E, Amelio E, Corrado B, Galasso O, Cugola L, et al.[The ESWT in the treatment of pseudoorthtosis: The osteoangiogenetic response] Giornale Italiano di Ortopedia e Trumatologia 2000; 26: 6-12.
15. Siebrt W, Buch M. Extracorporeal shock wave in orthopaedics. Heidelberg: Springer-Verlag Berlin; 1998.
16. Valchanov VD, Michailov P. High energy shock waves in the treatment of delayed and nonunion of fractures. Int Orthop 1991; 15: 181-184.
17. Rompe JD, Burger R, Hopf C, Eysel P. Shoulder function after extracorporeal shock wave therapy for calcific tendinitis. J Shoulder Elbow Surg 1998; 7: 505-509. (Pubitemid 128645664)
18. Loew M, Deacke W, Kusnierczak D, Rahmanzadeh M, Ewerbeck V. Shock-wave therapy is effective for chronic calcifying tendinitis of the shoulder. J Bone Joint Surg 1999; 81B: 863-867. (Pubitemid 29438365)
19. Rompe JD, Hopf C, Kullmer K, Heine J, Burger R. Analgesic effect of ESWT on chronic tennis elbow. J. Bone Joint Surg 1996; 78B: 233-237. (Pubitemid 26096999)
20. Rompe JD, Decking J, Schoellner C, Nafe B. Shock wave application for chronic plantar fascitis in running athletes: a prospective, randomized, placebo-controlled trial. Am J Sports Med 2003; 31: 68-75. (Pubitemid 36343335)
21. Orhan Z, Alper M, Akman Y, Yavuz O, Yalciner A. An experimental study on the application of extracorporeal shock waves in the treatment of tendon injuries: preliminary report. J Orthop Sci 2001; 6: 566-570. (Pubitemid 34019566)
22. Manganotti P, Amelio E. Long term effect of shock wave therapy on upper limb hypertonia in patients affected by stroke. Stroke 2005; 36: 1967-1971. (Pubitemid 41266535)
23. Manganotti P, Zaina F, Falso M, Milanese F, Fiaschi A. Evaluation of botulinum toxin of spastic equinus in paediatric patients with cerebral palsy. J Rehabil Med 2007; 39: 115-120.
24. Gotte G, Amelio E, Russo S, Marlinghaus E, Musei G, Suzuki H. Short-time non-enzymatic nitric oxide synthesis from L-arginine and hydrogen peroxide induced by shock waves treatment. FEBS Letts 2002; 520: 153-155.
25. Mariotto S, Cavalieri E, Ciampa A, Carcereri de Prati A, Amelio E, Russo S, et al. Effect of shock wave on the catalytic activity of endothelial nitric oxide synthase in umbilical vein endothelial cells. Ital J Biochem 2003; 52: 16-20.
26. Mariotto S, Cavalieri E, Amelio E, Campa AR, Carcereri de Prati A, Marlinghaus E, et al. Extracorporeal shock waves: from lithotripsy to anti-inflammatory action by NO production. Nitric Oxide 2005; 12: 89-96. (Pubitemid 40312450)
27. Ciampa AR, Carcereri de Prati A, Amelio E, Cavalieri E, Persichini T, Colasanti M, et al. Nitric oxide mediates anti-inflammatory action of extracorporeal shock waves. FEBS Letts 2005; 579: 6839-6845. (Pubitemid 41773696)
28. Blottner D, Luck G. Just in time and place: NOS/NO system assembly in neuromuscular june formation. Micros Res Tech 2001 ; 55: 171-180.
29. Molina JA, Jimenez Jimenez FJ, Orti Paregja M, Navarro JA. The role of nitric oxide in neurodegeneration. Potential for pharmacological intervention. Drugs Aging 1998; 12: 251-259.
30. Leone JA, Kukulka CG. Effects of tendon pressure on alpha motoneuron excitability in patients with stroke. Phys Ther 1988; 68: 475-480.